RadNet, Inc. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
RadNet, Inc. (RDNT) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of -$14.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2025-03-03
- RadNet, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was -$14.00K.
- RadNet, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- RadNet, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $79.00K.
- RadNet, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$14.00K 10-K · filed 2025-03-03 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 | |
| 2022-12-31 | $79.00K 10-K · filed 2024-02-29 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2020-12-31 | $2.00K 10-K · filed 2023-03-01 | |
| 2019-12-31 | $21.00K 10-K · filed 2022-03-01 | -$1.52M 10-K · filed 2020-03-16 |
| 2018-12-31 | -$171.00K 10-K · filed 2021-03-16 | $1.13M 10-K · filed 2019-03-18 |
| 2017-12-31 | $1.85M 10-K · filed 2020-03-16 | $1.16M 10-K · filed 2018-03-19 |
| 2016-12-31 | $2.55M 10-K · filed 2019-03-18 | |
| 2015-12-31 | $356.00K 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |